PGP and glioblastoma: Additional support for TMZ being a substrate for these efflux transporters is derived from studies indicating that the deletion of genes encoding P-gp and BCRP, or the pharmacological inhibition of these proteins with elacridar, significantly enhanced the anti-tumor efficacy of TMZ against orthotopically implanted GBM tumors in mice [45].